baber/WOPTO huggingface dataset:
Patent AU-2136200-A (AU)
Title: Modification of interferon alpha production
Inventor: BERGLUND ASA
IPC: C12R1/91
Filed: 1999-12-22
Abstract: A process for the production of alpha-interferon comprising the steps: i) inducing of human leukocytes by means of a virus; ii) treating the leukocytes with an enhancing agent selected from: a) Xanthine, pyrimidinol and pyrimidinone or derivatives of anyone thereof, such as theophylline, 2-amino-5-bromo-6-methyl-4 pyriminidol or thymine; b) an organic solvent selected from the group consisting of non-aromatic ketones, aliphatic or cyclic amides, alkylated aliphatic or cyclic urea derivatives and aliphatic or cyclic sulfoxides, such as N-methyl-2-pyrrolidinone, acetone, 2-butanone, 1,3-dimethyl-2-imidazolidinone, dimethylsulfoxide, 4-methyl-2-pentanone-N-ethyl-2-pyrrolidinone, 2-pyrrolidinone, tetramethylene sulfoxide or N,N-dimethylacetamide; or a combination of the compounds from a) with an organic solvent from b).
Patent AU-2223399-A (AU)
Title: Impoundment leak detection, location, and containment system and method with mobile sensor
Inventor: HAMPTON BURT T
IPC: G01M3/38
Filed: 1999-01-12
Abstract: An impoundment leak detection, location, and containment system includes a leak detection and location structure positioned below the impoundment with a system of conduit spanning substantially all of the extent under the impoundment. A mobile sensor system can be maneuvered through the conduit and into the leak detection and location structure to identify and locate leaks in the impoundment above. The system also includes a hydrocarbon sealing compound which has a sealing effect when exposed to fluids containing water and/or hydrocarbon liquids.
Patent AU-2225795-A (AU)
Title: Method for removing sulphur dioxide from a gas
Inventor: AHMAN STEFAN
IPC: B01D53/50
Filed: 1995-02-27
Abstract: PCT No. PCT/SE95/00203 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Feb. 27, 1995 PCT Pub. No. WO95/26807 PCT Pub. Date Oct. 12, 1995A method for removing sulphur dioxide from a gas, such as a flue gas, is disclosed. In the method, the sulphur-dioxide-containing gas is conducted upwards through at least one layer of aqueous absorbent suspension, whose absorbent is lime or limestone, the volume of the suspension layer being about 100-1000 l, calculated per m3 of sulphur-dioxide-containing gas flowing through the layer every second, the static height of the layer being at least about 20 mm, preferably about 300-600 mm, and the gas flow through the layer being such that turbulence is generated in the layer, that the pH of the absorbent suspension is adjusted to about 3.0-5.5 with the aid a buffer, preferably adipic acid, and that, separately from the sulphur-dioxide-containing gas, an oxygen-containing gas, preferably air, is supplied to the layer of absorbent suspension, preferably to the lower part of the layer of absorbent suspension and in such an amount that the molar ratio of oxygen to sulphur dioxide supplied to the suspension layer ranges from about 1:1 to about 25:1.
Patent AU-2358188-A (AU)
Title: Disposable absorbent articles for incontinent individuals
Inventor: JORDAN WILLIAM EUGENE
IPC: A61F13/15
Filed: 1988-10-10
Abstract: Absorbent articles containing both an acidic buffering agent and a non-toxic, non-irritating, non-volatile antimicrobial agent are disclosed. The acidic buffering agent is preferably also an absorbent gelling agent which can imbibe aqueous body fluids in addition to acting as a buffer. Such articles are especially suitable for maintaining the pH or urine and feces discharged into the article at value below about 7.5. This in turn helps to prevent or reduce diaper rash and control odor caused by the production of ammonia.
Patent AU-2377588-A (AU)
Title: Controlled absorption diltiazem formulations
Inventor: GEOGHEGAN EDWARD JAMES
IPC: A61K31/352
Filed: 1988-10-14
Abstract: A controlled absorption diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a pharmaceutically acceptable film-forming, water insoluble synthetic polymer and optionally a minor proportion of a pharmaceutically acceptable film-forming, water soluble synthetic polymer. The number of layers in the membrane and the ratio of the water soluble to water insoluble polymer, when said water soluble polymer is present, being effective to permit release of diltiazem from the pellet at a rate allowing controlled absorption thereof over not less than a twelve hour period following oral administration. The pellet has a dissolution rate in vitro which when measured in a dissolution apparatus (paddle) according to U.S. Pharmacopoeia XXI in 0.05 M KCl at pH 7.0 results in not more than 35% of the total diltiazem being released after 2 hours of measurement. Not more than 60% of the total diltiazem is released after four hours of measurement and 100% of the diltiazem is released no earlier than after 8 hours of measurement in said apparatus.
Patent AU-2640492-A (AU)
Title: Hemostatic implant introducer
IPC: A61B17/00
Filed: 1992-09-17
Abstract: A puncture seal device for stemming the flow of blood from a punctured blood vessel includes an elongated outer sheath affixed to a generally tubular housing where the housing contains a manually actuable slide which is affixed to a rigid tubular pusher member coaxially disposed within the outer sheath. Also contained within the outer sheath in longitudinal alignment with the pusher and distally thereof is a ring-shaped plug of a hemostatic material. The assembly thus far described may be fitted over a tubular introducer or the body of a catheter and then advanced therealong until the distal end of the outer sheath is proximate a bleeding blood vessel. By actuating the pusher member, the hemostatic plug surrounding the introducer or catheter is ejected from the distal end of the outer sheath and held in abutting relationship to the bleeding blood vessel.
Patent AU-2725399-A (AU)
Title: Substituted isoindolones and their use as cyclic gmp modulators in medicaments
Inventor: SCHINDLER URSULA
IPC: C07D401/04
Filed: 1999-02-12
Abstract: The present invention relates to substituted isoindolone derivatives of the formula I,in which R1, R2, R3, R4, R5, R6 and R7 are as defined in the claims, which are useful pharmaceutically active compounds for the therapy and prophylaxis of illnesses, for example cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis. The compounds of the formula I are capable of modulating the body's production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the therapy and prophylaxis of illnesses which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of the formula I, to their use for the therapy and prophylaxis of the abovementioned illnesses and for preparing pharmaceuticals for these, and also pharmaceutical preparations which comprise compounds of the formula I.
Patent AU-2760200-A (AU)
Title: Stent with variable wall thickness
Inventor: KULA JOHN S
IPC: A61F2/06
Filed: 2000-04-07
Abstract: A stent is made flexible along its length. The stent initially starts as a metal sheet. It is rolled in its central region to a specified wall thickness. Thereafter, the stent is photochemically etched to produce the desired cell pattern of the design of the stent. Then, the stent is folded and the metal is joined to give rise to a stent with multiple wall thickness. For instance, larger wall thicknesses at the end of the stent versus smaller wall thicknesses at its center. Various other possible manufacturing methods are useful with respect to this stent. The stent can also be produced in an initial tube shape. The tube can be etched several times to get varying wall thickness. <IMAGE>
Patent AU-2820792-A (AU)
Title: Storage-stable formulation of fluorescent whitening mixtures
IPC: D06L4/664
Filed: 1992-11-06
Abstract: Storage-stable formulations of mixtures of optical brighteners containing at least two anionic optical brighteners, which preferably contain at least one sulphonic acid radical; an anionic polysaccharide; dispersants and water and optionally also auxiliaries. These formulations are particularly suitable for the production of liquid detergents.
Patent AU-2871897-A (AU)
Title: Fructan- and/or polydextrose-containing dairy powders, process for preparing same and their use
Inventor: BOOTEN KARL
IPC: A23L33/21
Filed: 1997-07-17
Abstract: The present invention relates to fructan- and/or polydextrose-containing dairy powders. These powders are obtained by co-drying of the dairy and at least one ingredient selected from the group consisting of linear fructans, branched fructans, modified fructans and polydextrose. These powders improve the mouthfeel, texture and taste of the food compositions wherein they are used.
Patent AU-3029501-A (AU)
Title: Aqueous ionic solutions and their uses in particular in ophthalmology
Inventor: YVIN JEAN-CLAUDE
IPC: A61K35/08
Filed: 2000-12-28
Abstract: The invention concerns the use for treating and cleaning the eye and its appendages of aqueous ionic solutions obtained from sea water whereof the ionic composition is qualitatively that of sea water and quantitatively such that their pH ranges between 4 and 9, preferably between 7 and 8 and their osmolality ranges between 150 and 700, preferably between 250 and 350 mOsm/kg.
Patent AU-3229789-A (AU)
Title: Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
Inventor: CHIESI PAOLO
IPC: A61K31/54
Filed: 1989-03-31
Abstract: Aqueous pharmaceutical formulations containing the active principle piroxicam or N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxyamido-1 ,1-dioxiHY # de, are described. The compositions of the invention are particularly suited for the injectable use, both because of their tolerability degree and for the favourable pharmacokinetics profile and may be advantageously used also for the preparation of collyria or eye-washes.
Patent AU-3443289-A (AU)
Title: Sagger loading apparatus and a method of loading a sagger
Inventor: HARROW GEORGE ARTHUR
IPC: F27D3/00
Filed: 1989-04-18
Abstract: Sagger loading apparatus, for loading unfired ceramic sparking plug bodies (3) into a sagger (37), includes a clamp (8) for removing the bodies from a conveyor (2) and depositing the bodies on pins (14) in an array, which form an intermediate store. A gripper assembly having four inwardly and outwardly movable walls (22) grips the bodies on the pins and removes them and moves them simultaneously into the sagger, where the walls of the gripper are moved apart to leave the sparking plug bodies in the sagger, ready for firing.
Patent AU-3490989-A (AU)
Title: Filtering and collecting device of solid and powder refuse for industrial and civil suction apparatus
IPC: A47L5/28
Filed: 1989-05-18
Abstract: The apparatus is equipped with at least one flexible, removable storage bag (17) and means (4) of drawing in and conveying refuse to the storage bag (17) adapted to form a flow of air and refuse, the filtering and collecting device comprising: an air and refuse sorting zone (16a) supplied with the flow of air and refuse, at least one filter (19) communicated with the sorting zone (16a) and adapted to allow for the escape of air from the flow, and the storage bag (17) communicated with the sorting zone (16a) and made of an impervious material of the disposable type, to be thrown away together with refuse collected therein.
Patent AU-3857885-A (AU)
Title: Method and device for preventing cross direction web shrinkage in the drying section of a paper machine
IPC: D21F5/00
Filed: 1985-02-08
Abstract: It is a known phenomenon that the web during the drying moment in a paper machine shrinks. The shrinkage in the machine direction can be controlled by arranging the different driving groups in the drying section to operate at different speeds. The shrinkage in cross direction, however, heretofore was not brought under control. The present invention has the object to solve thos problem. 
<??>According to the invention, the problem of shrinkage is solved in that the web during a certain drying interval is subjected to outward directed forces, which are applied during a suitable drying interval and preferably at a low dry content, for example directly after the press section.
Patent AU-3940593-A (AU)
Title: Benzodiazepine derivatives and protein and polypeptide conjugates thereof
Inventor: BUECHLER KENNETH FRANCIS
IPC: C07K14/705
Filed: 1993-03-31
Abstract: The present invention is directed to novel benzodiazepine derivatives which are synthesized for the covalent attachment to antigens (proteins or polypeptides) for the preparation of antibodies or receptors to the benzodiazepine metabolites. The resulting novel antigens may be used for the production of antibodies or receptors using standard methods. Once generated, the antibodies or receptors and the novel derivatives which are covalently attached to proteins, polypeptides or labels may be used in the immunoassay process.
Patent AU-3944601-A (AU)
Title: Extrusion die
Inventor: FELDCAMP EDWARD GEORGE
IPC: B29C48/32
Filed: 2001-03-27
Abstract: An extrusion die comprises a die body defining a die cavity (18). The cavity (18) is shaped such that the die body includes a male portion (24) and a female portion (26). A leading edge (18a) of a part of one side of the die cavity (18) is out of alignment with a leading edge (18a) of an opposing part of the die cavity (18), at rest, such that, in use, when deflection of parts of the die occurs, the leading edges (18a) substantially align.
Patent AU-4013989-A (AU)
Title: Process and apparatus for the manufacture of a corrugated wafer board panel
Inventor: BACH LARS
IPC: B27N5/00
Filed: 1989-08-22
Abstract: A platen assembly is provided having a working surface which can be mechanically converted between planar and corrugated configurations. A mat of wood wafers (27) coated with thermosetting resin binder is deposited between upper and lower, spaced apart platen assemblies (1) of this type. The platen assemblies (1), in the planar configuration, are then pressed together to a limited extent to pre-compress the mat to fix the wafers. Horizontal force is then applied to the platen assemblies to convert them to the corrugated configuration, with the pre-compressed mat retained therebetween. The mat is therefore forced to adopt a corrugated form. The platen assemblies are then further pressed together and heated, to cure the resin and produced a corrugated wafer board panel.
Patent AU-4105289-A (AU)
Title: Cycloalkyl-substituted glutaramide antihypertensive agents
IPC: C07D209/20
Filed: 1989-09-04
Abstract: Compounds of the formula: <CHEM> Wherein A completes a 5 or 6 membered carbocyclic ring which may be saturated or monounsaturated; R<1> is H or (C1-C4)alkyl; R and R<4> are H, (C1-C6)alkyl, C3-C7 cycloalkyl, benzyl, or an alternative biolabile ester-forming group; Y is either a direct bond or an alkylene group of from 1 to 6 carbon atoms; R<2> is H, aryl, heterocyclyl, R<6>CONR<5>-, R<7>NR<5>CO-, R<7>NR<5>SO2- or R<8>SO2NR<5>-, with the proviso that Y is not a direct bond when R<2> is H, aryl or heterocyclyl; wherein R<5> is H, (C1-C6)alkyl or aryl(C1-C6)alkyl; R<6> is (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl, heterocyclyl(C1-C6)alkyl or a group of the formula R<9>R<1><0>R<1><1>C- wherein R<9> is H, OH, (C1-C6)alkoxy, (C1-C6)alkyl, hydroxy(C1-C6)alkyl, aryl(C1-C6)alkyl, (C2-C6)alkenyl, heterocyclyl, heterocyclyl(C1-C6)alkyl, R<1><2>CONH-, R<1><2>SO2NH- or (R<1><3>)2N-; R<1><0> and R<1><1> are H or (C1-C6)alkyl; or R<1><0> is H and R<1><1> is amino(C1-C6)alkyl, imidazolylmethyl, aryl, aryl(C1-C6)alkyl, aryl(C1-C6)alkoxy(C1-C6)alkoxy, hydroxy(C1-C6)alkyl or methylthio(C1-C6)alkyl; or the two groups R<1><0> and R<1><1> form a 3 to 6 membered carbocyclic ring or a pyrrolidine or piperidine ring which may optionally be substituted by amino, (C2-C4)alkanoyl or aroyl; R<1><2> is (C1-C6)alkyl, (C3-C7)cycloalkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl; each R<1><3> is H, (C1-C6)alkyl, aryl(C1-C6)alkyl or the two groups R<1><3> form a pyrrolidinyl, piperidino, morpholino, piperazinyl or N-(C1-C4)alkyl-piperazinyl group; R<7> is (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl, heterocyclyl(C1-C6)alkyl or a group of the formula R<1><0>R<1><1>R<1><4>C- wherein R<1><0> and R<1><1> are as previously defined and R<1><4> is (R<1><3>)2NCO-, R<1><2>OCH2- or R<1><5>OCO, wherein R<1><2> and R<1><3> are as previously defined and R<1><5> is (C1-C6)alkyl, (C3-C7)cycloalkyl or aryl(C1-C6)alkyl; and R<8> is (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl, heterocyclyl or heterocyclyl(C1-C6)alkyl;  R<3> is a group of the formula: <CHEM> wherein R<1><6> is H, halo, 4-OH, 4-(C1-C6 alkoxy), 4-(C3-C7 cycloalkoxy) 4-(C2-C6 alkenyloxy), 4-[(C1-C6 alkoxy)carbonyloxy], 4-[(C3-C7 cycloalkoxy)carbonyloxy], or 3-(C1-C4 alkyl)SO2NH-; and R<2><0> is H, C1-C4 alkyl, C1-C4 alkoxy, C2-C6 alkanoyl or halo; or R<3> is a group of the formula: <CHEM> wherein said groups may optionally be substituted in the fused benzene ring by C1-C4 alkyl, C1-C4 alkoxy, OH, halo or CF3; are antihypertensive agents of utility in the treatment of hypertension, heart failure and renal insufficiency.
Patent AU-4154896-A (AU)
Title: Desensitizing teeth with degradable particles
Inventor: MASTERMAN THOMAS CRAIG
IPC: A61K8/04
Filed: 1995-11-09
Abstract: A method for desensitizing a hypersensitive tooth in a patient includes contacting exposed tubules with particles including a degradable material.
Patent AU-4176101-A (AU)
Title: Universal catheter anchoring system
Inventor: BIERMAN STEVEN F
IPC: A61M25/02
Filed: 2001-02-23
Abstract: A method of securing a medical article to the body of a patient is disclosed in which an anchoring device comprising an anchor and a retainer is used. The retainer is attached to an upper surface of the anchor and comprises a base, a cover and a post. The base is disposed on the upper surface of the anchor and the cover is connected to the base so as to move between an open and a closed position. When the cover is in the closed position, it lies above at least part of the base. The post is attached movably to either the base or the cover and is arranged so as to lie at least partially between the cover and the base when the cover is in the closed position. When securing a medical article, the cover is placed in the open position and the medical article placed onto the retainer. The cover may then be closed over the medical article and the anchoring device attached to the patient.
Patent AU-4435589-A (AU)
Title: Agitator ball mill
Inventor: DURR HERBERT
IPC: B02C17/16
Filed: 1989-11-02
Abstract: A stirring mill has a grinding container (1) having a cylindrical grinding chamber (30) bounded by a grinding chamber wall (42). Arranged in said grinding chamber there is at least one stirring apparatus (15) provided with projecting stirring tools (17). The stirring apparatus (15) and the grinding container (1) can be rotary-driven about their respective axes (25, 6) which are parallel to each other. The grinding chamber (30) is partially filled with auxiliary grinding bodies (33) and has a feeder (29) of products to be ground and a discharge of ground products having a separating device (35) separating ground products and grinding bodies. 
<??>In order to allow both wet comminution and dry comminution, the axis (25) of the stirring apparatus has an eccentricity (e) relative to the longitudinal mid-axis (6) of the grinding chamber (30). Furthermore, provided in the region of the grinding chamber wall (42) is at least one stationary deflector (41) directed from said grinding chamber wall into the grinding chamber (30) and extending over a substantial part of the length of the grinding chamber (30), which deflector has a deflection surface which is open towards the longitudinal mid-axis (6). 
<IMAGE>
Patent AU-4451785-A (AU)
Title: Adding solids to liquid flow for conveying
Inventor: JANSSEN KLAUS
IPC: B65G53/30
Filed: 1985-07-03
Abstract: Solids particles are conveyed hydraulically by first mixing the solids particles with a liquid in order to form a viscous material of substantially uniform consistency. This viscous material is then introduced or injected into a flowing hydraulic medium that had been substantially free of solids prior to this viscous material injection in order to form a hydraulically conveyed flow. Variations in conduit cross-section at or near the location of viscous material injection may be provided in order to enhance turbulance and suspension of solids within the hydraulically conveyed flow.
Patent AU-4645793-A (AU)
Title: Elevator brake with shoes actuated by springs
Inventor: GLASER WALTER
IPC: B66B5/24
Filed: 1993-06-22
Abstract: An elevator car braking system in which a pair of brake shoes engage and grip the hoisting ropes, part of the hoisting apparatus or the car guide rails when compressed springs, which are normally held in a compressed state by an electrically operable locking assembly, are released. The springs are compressible by a fluid operable piston and cylinder assembly. The springs move a cam follower, linked to one of the shoes, along cam surfaces shaped and disposed to cause the cam follower to move one brake shoe toward the other brake shoe. The locking assembly is responsive to car speed and/or movement of the car from a floor with its doors open. Switches operable by the cam follower control the car electrical controls so that movement of the car is prevented when the springs are not compressed and when there is excessive shoe wear.
Patent AU-4672300-A (AU)
Title: Biochemical methods that eliminate corneal scars, opacification and haze
Inventor: KARAGEOZIAN HAMPAR
IPC: A61K38/49
Filed: 2000-04-28
Abstract: The invention disclosed herein relates to biochemical methods for the elimination of corneal collagen fiber disorganization to improve vision. Disorganization of corneal collagen fibers is seen in corneal scars, corneal opacification and corneal haze. In addition, the invention relates to biochemical methods for the elimination of corneal collagen fiber disorganization resulting from accidental traumatic injury to the cornea and from refractive surgery for such as radial keratotomy (RK), photorefractive keratectomy (PRK), and laser in situ keratomileusis (LASIK) so as to improve visual acuity and quality of vision.
Patent AU-4724599-A (AU)
Title: Treatment of hyperproliferative disorders
Inventor: MAURER BARRY JAMES
IPC: A61K31/535
Filed: 1999-06-28
Abstract: A method of treating a hyperproliferative disorder in a subject in need of such treatment, comprising administering to said subject, in combination, a treatment effective amount of: (a) a ceramide-generating retinoid such as fenretinide or a pharmaceutically acceptable salt thereof; and (b) at least one (and in certain embodiments at least two) ceramide degredation inhibitor, such as compounds selected from the group consisting of (i) glucosylceramide synthesis inhibitors, (ii) sphingosine-1-phosphate synthesis inhibitors, and (iii) protein kinase C inhibitors. A preferred glucosyl ceramide synthesis inhibitor is 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol. A preferred sphingosine-1-phosphate synthesis inhibitor is D-erythro-N,N-dimethylsphingosine. A preferred protein kinase C inhibitor is L-threo-dihydrosphingosine.